PM 012

Drug Profile

PM 012

Alternative Names: PM012 tablet - PuriMED

Latest Information Update: 25 Apr 2016

Price : $50

At a glance

  • Originator PuriMED
  • Class Antidementias; Herbal medicines
  • Mechanism of Action
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase II Alzheimer's disease

Most Recent Events

  • 31 May 2012 Phase-II clinical trials in Alzheimer's disease in South Korea (PO)
  • 31 Dec 2008 Preclinical trials in Dementia in South Korea (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top